Seattle Genetics announces proposed public offering of common stock
Seattle Genetics announced an underwritten public offering of 6,000,000 shares of its common stock. Seattle Genetics expects to grant underwriters of the offering a 30-day option to purchase up to an additional 900,000 shares of its common stock solely to cover overallotments. July 23, 2019